BIOVOLF

About:

We have developed a bioreactor technology that harnesses CO2 during operation and produces Wolffia, a high-quality, plant-based protein.

Website: https://www.biovolf.com/

Top Investors: Pole of time

Description:

Biovolf is a biotech company. We have developed a fully automated sustainable bioreactor technology that produces high-quality plant-based protein from Wolffia and harnesses CO2 during operation. The advantages of our bioreactor solution are: • Operates 24/7; 365 days a year; • Suitable for any climate, provides a weekly harvest; • Requiring only water and electricity to run. Biovolf’s technology is aimed at the 4 UN’s SDG Agenda Goals. Already raised $1,1M. HQ – Singapore; 2 branches in the UAE. Next round offer - $5M for 15% equity. Goal: 3x company valuation growth in 18 months Go-to-market strategy: Own production + TaaS scaling (royalty fees) Unit economics: Production cost $2/kg; market price: $4-35